Plain-English translation of NCT06298461 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn Disease research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Before a colonoscopy, patients need to clean out their bowels so doctors can see clearly. This trial is testing two different bowel-cleaning solutions — oral sulfate solution and a solution called polyethylene glycol — to find out which one works better and which one patients find easier to use. The study involves people with Crohn's disease or ulcerative colitis who are scheduled for a colonoscopy.
People with inflammatory bowel disease often struggle with bowel-cleaning medications because of their underlying condition, sometimes finding them hard to tolerate or not effective enough. This trial aims to identify which of these two medications is most reliable and easiest for IBD patients to use before their important screening test.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take one of the two bowel-cleaning solutions before your scheduled colonoscopy. You would follow the preparation instructions at home, then come in for your colonoscopy as planned. The study team would ask you questions about how well the medication worked and how easy or difficult it was for you to tolerate, helping them understand which solution is better for people with IBD.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Canada